請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/8371
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 潘敏雄(Min-Hsiung Pan) | |
dc.contributor.author | Pei-Sheng Lee | en |
dc.contributor.author | 李培聖 | zh_TW |
dc.date.accessioned | 2021-05-20T00:52:58Z | - |
dc.date.available | 2025-07-28 | |
dc.date.available | 2021-05-20T00:52:58Z | - |
dc.date.copyright | 2020-08-04 | |
dc.date.issued | 2020 | |
dc.date.submitted | 2020-07-28 | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/8371 | - |
dc.description.abstract | 大腸直腸癌 (colorectal cancer, CRC) 為各個國家普遍盛行的癌症,在台灣地區的統計中癌症發生率排名第一,流行病學調查顯示肥胖及西化的飲食習慣會提升罹患腸癌風險,發炎性腸道疾病 (inflammatory bowel disease) 患者亦會增加併發腸癌機會。越來越多的證據指出,在致癌過程中肥胖、腸道菌相及腸炎與飲食和發炎引起之改變息息相關,肥胖與大腸直腸致癌過程密切相關且已成為新興議題,然其分子機制仍待釐清,有鑒於此,就癌症化學預防 (chemoprevention) 的立場觀之,藉由抑制肥胖誘導的發炎反應、調節腸道菌相與分子機制,進而抑制大腸直腸癌形成應為更適切的預防策略。因此本研究以三部分延續性實驗探討植化素如何抑制高脂飲食誘導肥胖促進之潰瘍性腸癌發展及腸道菌相組成。本研究使用 garcinol 及 stilbenoid 化合物這兩類植化素進行實驗,在第一部分,利用高脂飲食 (high-hat-diet, HFD) 誘導肥胖之小鼠模式,探討 garcinol 抑制肥胖之機制,結果指出 garcinol 可改善高脂飲食誘導的小鼠肥胖,且呈劑量效應,並可逆轉高脂飲食誘導的腸道菌相失調,而參與脂肪細胞脂質新生的 AMP-activated protein kinase α (AMPKα) 路徑也受到 garcinol 的影響。顯示 garcinol 可作為一新型腸道菌相調節劑以預防高脂飲食誘導的腸道菌相失衡和肥胖相關的代謝疾病。在第二部分,先以細胞實驗從stilbenoids 化合物中選出抗發炎及抗脂質新生能力最佳的 3'-hydroxypterostilbene (HPSB),再以高脂飲食促進 dextran sodium sulfate (DSS) 誘導腸潰瘍動物模式探討 HPSB 在肥胖誘導的發炎反應及腸炎之保護作用與相關之分子機制。結果顯示 HFD+DSS 誘導組的腸炎較 DSS 組更為嚴重,而在不同時間點給予 0.025% 的 HPSB 可以改善高脂飲食誘導肥胖促進之小鼠腸潰瘍,並顯著降低 cyclooxygenase-2 (COX-2) 及 plasmalemma vesicle-associated protein-1 (PV-1) 的蛋白表現和 signal transducer and activator of ranscription 3 (STAT3) 的磷酸化作用,進而達到化學預防的效果。結果證實 HPSB 為一種能夠預防高脂飲食誘導肥胖促進之腸潰瘍的良好化學預防試劑。第三部分則以高脂飲食促進 azomethane (AOM)/DSS 誘導潰瘍性腸癌動物模式探討 garcinol 在肥胖誘導的腫瘤發展機制化學預防功效及腸道菌相組成。結果顯示,HFD+AOM/DSS 誘導組與給予 AOM/DSS 的組別相比其腸癌情形較嚴重,而給予 0.05% 的 garcinol 可顯著改善高脂飲食促進之潰瘍性腸癌發展。此外,以細胞激素評估小鼠體內發炎程度,經 HFD+AOM/DSS 誘導後,小鼠血清中 tumor necrosis factor alpha (TNF-α) 及 monocyte chemoattractant protein-1 (MCP-1) 受誘導而上升,給予 garcinol 則可減少促發炎細胞激素生成並調節失衡的血清生化值。在腸道菌相的部分,從優勢菌種氣泡圖及主成分分析 (principal component analysis, PCA) 結果可知,各組腸道菌相組成皆有顯著差異並分群,其差異在 Alistipes、Romboutsia 及 Ruminococcus 這些菌屬中最具有代表性。進一步使用典範對應分析 (canonical correspondence analysis, CCA) 找出影響菌相組成的重要驅動因子,結果顯示腫瘤數目、TNF-α、MCP-1 及糞便 pH 值皆顯著影響。為了瞭解分子機制如何調控,使用 RNA 定序 (RNA sequencing) 比較不同實驗條件下轉錄體 (transcriptome) 的變化,以火山圖找出差異基因後,接著利用 GSEA (gene set enrichment analysis) 找出差異較大的基因集 (gene sets),並以 KEGG (kyoto encyclopedia of genes and genomes) 資料庫進行比對分析,分析後的基因結果皆顯示給予 garcinol 可調節基因並改善高脂飲食促進之潰瘍性腸癌。綜合上述,植化素具有預防肥胖促進之潰瘍性腸癌發展的潛力,期以此研究結果為基礎,在科學上提供植化素在癌症化學預防與保健的機制,在食品的角度上則提供不同飲食攝取方式對生理的影響及功效,並可於經濟層面應用於開發植化素相關機能保健產品或輔助治療試劑。 | zh_TW |
dc.description.abstract | Colorectal cancer (CRC) is one of the major causes of cancer-related mortality in both men and women worldwide. The incidence of cancer currently ranks first in Taiwan. Epidemiological surveys have shown that obesity and westernized diet can increase the risk of colorectal cancer. Obesity and inflammatory bowel disease are closely related to the colorectal carcinogenesis process. The obesity -related colorectal cancer has become an emerging issue. However, its molecular mechanism remains unclear. Based on the principles of cancer chemoprevention, targeting on suppression of obesity-induced inflammation and modulation of microbiota were known to be an approprite strategy for CRC prevention. Therefore, a three-part continual experiment was conducted to investigate the chemopreventive efficacy of phytochemicals on obesity-promoting colitis and colitis-induced colon tumorigenesis. The phytochemicals chosen in the studies were garcinol and stilbenoids. In the first part, the results showed that garcinol reduced high-fat-diet (HFD)-fed mice obesity in a dose-dependent manner. Furthermore, the 16S rRNA gene sequence data indicated that garcinol not only reversed HFD-induced gut dysbiosis but also attenuated inflammation by increasing the intestinal commensal bacteria, Akkermansia. In addition, the AMP-activated protein kinase α signaling pathway involved in adipocyte adipogenesis was also regulated by garcinol. Taken together, these results demonstrate for the first time that garcinol can prevent HFD-induced obesity and may act as a novel gut microbiota modulator to prevent HFD-induced gut dysbiosis and obesity-related metabolic disorders. In the second part, this study confirmed that the HFD could promote the deterioration of colitis in mice. In compared, the results also showed that 3′-hydroxypterostilbene (HPSB) could be an effective inhibitor for purpose of anti-adipogenesis and anti-inflammation. Therefore, HPSB was used to investigate the protective effect and related molecular mechanisms of HPSB on HFD-promoting dextran sodium sulfate (DSS)-induced colitis in mice. Our results indicate that colitis in the HFD+DSS group tends to be more severe than the DSS-only group, while feeding 0.025% of HPSB at different stages could improve the colitis induced by HFD+DSS. Moreover, HPSB significantly downregulated the expression of cyclooxygenase-2 (COX-2) and plasmalemma vesicle-associated protein-1 (PV-1), and inhibited the phosphorylation of signal transducer and activator of transcription 3 (STAT3) in HFD+DSS treated mice. Presented results reveal that HPSB can be a novel functional agent capable of prevent HFD exacerbated colitis. In the last part of the experiment, an animal model to investigate the effect of HFD-induced obesity on promoting colitis-associated colon cancer (AOM (azomethane)/DSS-induced) was designed. The results evidenced that HFD promoted colitis-associated colon cancer as compared to AOM/DSS group without intervention of obesity, meanwhile supplementing 0.05% of garcinol in diet could significantly ameliorate obesity promoted colon carcinogenesis. Besides, the severity of inflammation was evaluated by cytokines status, the results show that the level of tumor necrosis factor alpha (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) were increased in HFD+AOM/DSS group, while taking garcinol could effectively reduced the upregulation of pro-inflammatory cytokines. According to the dominant species bubble chart and principal component analysis (PCA) results, microbiota composition of each group was significantly different and clustered. The most representative genus are Alistipes, Romboutsia, and Ruminococcus. Canonical correspondence analysis (CCA) is commonly used to find the important driving factors affecting the distribution of the microbiota. The results showed that the number of tumors, TNF-α, MCP-1, and stool pH significantly affected the experimental results, in terms of microbiota composition. In order to understand the underlying molecular mechanism, RNA sequencing was employed to compare the changes of the transcriptome under different experimental conditions, and to find out the differential expression of genes by the volcano plot. And use of GSEA (gene set enrichment analysis) to find out the specific gene sets. Followed by that, the KEGG (kyoto encyclopedia of genes and genomes) database can be used for comparison and analysis. The RNA- sequencing results showed that administration of garcinol could regulate genes and improve obesity-promoting colitis-associated colon carcinogenesis. In conclusion, our results suggest phytochemicals having the potential to prevent obesity promoted-colorectal carcinogenesis. In addition, we provided the scientific evidence for elucidation of the underlying mechanisms of phytochemicals in cancer chemoprevention. From the perspective of food, it can also provide the effects of different dietary intake on physiology, and can also be applied to the development of phytochemical-related functional foods or adjuvant therapeutic agents. | en |
dc.description.provenance | Made available in DSpace on 2021-05-20T00:52:58Z (GMT). No. of bitstreams: 1 U0001-2807202017494600.pdf: 15977266 bytes, checksum: 9d7fb532c1e0f797ce99694be2870b6b (MD5) Previous issue date: 2020 | en |
dc.description.tableofcontents | 口試委員會審定書 I 誌謝 II 中文摘要 IV Abstract VI 目錄 IX 附圖索引 XIII 附表索引 XIV 圖目錄 XV 表目錄 XVIII 縮寫表 XIX 第一章、文獻回顧 1 第一節、肥胖與腸道菌相 (obesity and gut microbiota) 1 (一)、肥胖對疾病之影響 1 (二)、腸道菌相對肥胖的影響 1 (三)、腸道菌相及植化素相關研究 2 (四)、調控脂肪細胞新生之分子訊息傳遞路徑 4 第二節、肥胖與腸潰瘍 (obesity-accelerated inflammatory bowel disease) 5 (一)、飲食、肥胖與發炎性腸道疾病 (inflammatory bowel disease) 5 (二)、調控肥胖促進腸潰瘍之分子訊息傳遞路徑 6 (三)、發炎性大腸疾病動物模式 8 第三節、肥胖與腸癌 (obesity and colorectal cancer) 10 (一)、飲食、肥胖與腸癌發展息息相關 10 (二)、肥胖與慢性發炎促進腸癌發展之過程 12 (三)、大腸直腸癌之動物模式 15 (四)、腸道菌在潰瘍性腸癌發展過程中扮演的角色 16 第四節、植化素 (phytochemical) 21 (一)、山竹子素 (garcinol) 21 (二)、Stilbenoid 化合物 22 第二章、總實驗目的與架構 27 第一節、研究目的 27 第二節、實驗架構 27 第三章、材料與方法 29 第一節、實驗材料 29 (一)、抗體 29 (二)、藥品試劑 30 (三)、分析套組 31 (四)、儀器設備 32 (五)、樣品來源 32 第二節、實驗方法 33 第一部份、山竹子素通過調節腸道菌相組成改善高脂飲食誘導之小鼠肥胖 33 (一)、實驗設計 33 (二)、飼料配製 34 (三)、臟器及血液處理 35 (四)、組織切片染色 (H E) 36 (五)、肝臟三酸甘油酯萃取及定量 (liver hepatic triglyceride) 38 (六)、組織均質及蛋白質萃取 39 (七)、16S rDNA 基因定序及分析 (16S rDNA gene sequencing and analysis) 39 (八)、西方墨點法 (western blot) 44 (九)、統計分析 46 第二部份、3′-hydroxypterostilbene 改善肥胖促進之小鼠腸潰瘍 47 A. 細胞實驗 (in vitro) 方法 47 (一)、樣品配製 (sample preparation) 47 (二)、細胞株 (cell line) 47 (三)、細胞存活率實驗 (MTT assay) 47 (四)、3T3-L1 前脂肪細胞誘導分化實驗 (adipocyte differentiation) 48 (五)、油紅染色實驗 (oil red O stain) 49 (六)、RAW264.7 巨噬細胞誘導發炎及 nitrite 測定 50 B. 動物實驗 (in vivo) 方法 52 (一)、動物實驗設計 52 (二)、飼料配製 53 (三)、臟器及血液處理 54 (四)、組織切片染色 (H E) 54 (五)、評估腸潰瘍指數 (disease activity index, DAI) 55 (六)、腸道中 aberrant crypt foci (ACF) 數目及分布情形分析 55 (七)、血清中 cytokines 及 adipokines 測定 55 (八)、組織均質及蛋白質萃取 56 (九)、西方墨點法 (western blot) 56 (十)、統計分析 56 第三部份、山竹子素抑制高脂飲食誘導肥胖促進之潰瘍性腸癌發展的化學預防功效 57 (一)、實驗設計 57 (二)、飼料配製 58 (三)、臟器及血液處理 59 (四)、組織切片染色 (H E) 60 (五)、評估腸潰瘍指數 (disease activity index, DAI) 60 (六)、組織免疫螢光染色 (immunofluorescence Stain) 60 (七)、血清中 cytokines 測定 62 (八)、16S rDNA 基因定序及分析 (16S rDNA gene sequencing and analysis) 62 (九)、盲腸糞便 pH 值測定 62 (十)、小鼠腸道 RNA 定序及分析 (RNA sequencing and analysis) 62 (十一)、統計分析 63 第四章、結果與討論 64 第一節 摘要 65 第一節、山竹子素透過調節腸道菌相組成改善高脂飲食誘導小鼠之肥胖 66 (一)、Garcinol 對高脂飲食誘導肥胖之小鼠體重及血清生化值影響 66 (二)、Garcinol 對高脂飲食誘導肥胖之小鼠白色脂肪組織脂肪細胞大小和肝臟脂質蓄積之影響 70 (三)、Garcinol 改善高脂飲食誘導肥胖之小鼠腸道菌相組成 75 (四)、Garcinol 改變高脂飲食誘導肥胖之小鼠腸道菌相及功能性預測 80 (五)、Garcinol 透過增加 Akkermansia 來調節 AMPK 訊息傳遞路徑並改善肥胖 85 第一節 結論 89 第二節 摘要 91 第二節、3′-hydroxypterostilbene 改善肥胖促進之小鼠腸潰瘍 92 (一)、Stilbenoids 化合物對分化之前脂肪細胞 3T3-L1 細胞毒性分析 92 (二)、Stilbenoids 化合物抑制 3T3-L1 細胞內脂質堆積之情形 92 (三)、Stilbenoids 化合物對小鼠巨噬細胞 RAW264.7 之細胞毒性分析 95 (四)、Stilbenoids 化合物抑制小鼠巨噬細胞 RAW264.7 發炎反應 95 (五)、3′-hydroxypterostilbene 對高脂飲食誘導肥胖促進之小鼠腸潰瘍對體重及腸道影響 97 (六)、3′-hydroxypterostilbene 對肥胖促進小鼠腸潰瘍之臟器及血清生化值影響 100 (七)、3′-hydroxypterostilbene 改善肥胖促進之腸潰瘍 aberrant crypt foci 生成及腸道潰瘍 105 (八)、3′-hydroxypterostilbene 改善肥胖促進之腸潰瘍小鼠 cytokines 及 adipokines 109 (九)、3′-hydroxypterostilbene 對高脂飲食誘導肥胖促進之小鼠腸潰瘍相關之分子傳遞路徑影響 109 第二節 結論 113 第三節 摘要 114 第三節、山竹子素抑制高脂飲食誘導肥胖促進之潰瘍性腸癌發展的化學預防功效 116 (一)、Garcinol 對高脂飲食誘導肥胖促進小鼠腸癌的體重及腸道影響 116 (二)、高脂飲食誘導肥胖促進之小鼠腸腫瘤變化及型態差異 116 (三)、Garcinol 對高脂飲食誘導肥胖促進之小鼠腸癌臟器及血清生化值影響 121 (四)、高脂飲食誘導肥胖促進之小鼠腸癌模式中 garcinol 對細胞激素及白血球之影響 127 (五)、Garcinol 對高脂飲食誘導肥胖促進之小鼠腸癌細胞增生指標 PCNA 之影響 129 (六)、Garcinol 改善高脂飲食誘導肥胖促進之腸癌小鼠腸道菌相組成 129 (七)、腸道菌相生物標記 (biomarker) 及影響菌相分布的驅動因子探討 138 (八)、透過 RNA 定序探討高脂飲食誘導肥胖促進之腸癌模式中差異基因 141 第三節 結論 148 第五章、總結論 150 參考文獻 152 已發表之國際期刊論文 164 附錄 168 | |
dc.language.iso | zh-TW | |
dc.title | Garcinol 及 3'-hydroxypterostilbene 在高脂飲食誘導的肥胖、腸炎及腸炎相關癌化的抑制作用 | zh_TW |
dc.title | Inhibitory effects of garcinol and 3'-hydroxypterostilbene in high fat diet-induced obesity, colitis, and colitis-mediated colon carcinogenesis | en |
dc.type | Thesis | |
dc.date.schoolyear | 108-2 | |
dc.description.degree | 博士 | |
dc.contributor.advisor-orcid | 潘敏雄(0000-0002-5188-7030) | |
dc.contributor.oralexamcommittee | 王朝鐘(Chau-Jong Wang),何元順(Yuan-Soon Ho),廖秀娟(Vivian Hsiu-Chuan Liao),王應然(Ying-Jan Wang),黃步敏(Bu-Miin Huang) | |
dc.subject.keyword | 高脂飲食,肥胖,大腸直腸癌,化學預防,植化素,腸道菌相, | zh_TW |
dc.subject.keyword | high-fat-diet,obesity,colorectal cancer,chemoprevention,phytochemical,microbiota, | en |
dc.relation.page | 169 | |
dc.identifier.doi | 10.6342/NTU202001989 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2020-07-29 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 食品科技研究所 | zh_TW |
dc.date.embargo-lift | 2025-07-28 | - |
顯示於系所單位: | 食品科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
U0001-2807202017494600.pdf 此日期後於網路公開 2025-07-28 | 15.6 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。